Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.

Diabetologia · 2026 · PMC13005873 · PMID 41535597

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

These findings suggest that teplizumab treatment may help stabilise or modestly improve HbA 1c levels, whereas untreated individuals with stage 2 type 1 diabetes showed a trend toward worsening glycaemic status over time.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.